Cabaletta Bio
CABA
52 hedge funds and large institutions have $183M invested in Cabaletta Bio in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 6
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
57% more capital invested
Capital invested by funds: $117M → $183M (+$66.3M)
27% more funds holding
Funds holding: 41 → 52 (+11)
26.64% more ownership
Funds ownership: 66.62% → 93.27% (+27%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.41M |
| 2 |
Millennium Management
New York
|
+$1.83M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.07M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$775K |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$766K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$6.28M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$361K |
| 3 |
Norges Bank
Oslo,
Norway
|
-$344K |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$304K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119K |
CABA Hedge Fund Activity: Q2 2020 in Review
52 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q2 2020, worth a combined $183M — up 57% from $117M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CABA positions and 4 closed out — a net gain of 11 holders — while 24 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $2.41M. The largest seller was Deerfield Management, cutting an estimated $6.28M.
- 52 institutional investors held Cabaletta Bio (CABA) as of Q2 2020, up from 41 in Q1 2020.
- Funds reported $183M of Cabaletta Bio stock for Q2 2020, up 57% quarter-over-quarter.
- 15 funds opened new Cabaletta Bio positions in Q2 2020 and 4 closed out, a net change of +11 holders.
- The largest Cabaletta Bio buyer in Q2 2020 was BlackRock, an estimated $2.41M added.
- The largest Cabaletta Bio seller in Q2 2020 was Deerfield Management, an estimated $6.28M sold.
Based on aggregated 13F filings for Q2 2020.